Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Construction in Progress (2018 - 2023)

Historic Construction in Progress for China SXT Pharmaceuticals (SXTC) over the last 6 years, with Q1 2023 value amounting to $349390.0.

  • China SXT Pharmaceuticals' Construction in Progress fell 377.0% to $349390.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $349390.0, marking a year-over-year decrease of 377.0%. This contributed to the annual value of $349390.0 for FY2023, which is 377.0% down from last year.
  • China SXT Pharmaceuticals' Construction in Progress amounted to $349390.0 in Q1 2023, which was down 377.0% from $363078.0 recorded in Q1 2022.
  • China SXT Pharmaceuticals' 5-year Construction in Progress high stood at $649235.0 for Q1 2019, and its period low was $328372.0 during Q1 2020.
  • For the 5-year period, China SXT Pharmaceuticals' Construction in Progress averaged around $409137.8, with its median value being $355614.0 (2021).
  • In the last 5 years, China SXT Pharmaceuticals' Construction in Progress tumbled by 4942.17% in 2020 and then skyrocketed by 829.61% in 2021.
  • China SXT Pharmaceuticals' Construction in Progress (Quarter) stood at $649235.0 in 2019, then crashed by 49.42% to $328372.0 in 2020, then grew by 8.3% to $355614.0 in 2021, then rose by 2.1% to $363078.0 in 2022, then decreased by 3.77% to $349390.0 in 2023.
  • Its Construction in Progress stands at $349390.0 for Q1 2023, versus $363078.0 for Q1 2022 and $355614.0 for Q1 2021.